Corporate News

Terveystalo (TTALO.HE) experienced a modest increase of 0.31 % during a 24‑hour trading window that concluded at 08:54 AM Central Europe on Thursday, 22 November 2026. At the close, one share of the Finnish healthcare provider traded for approximately EUR 6.39 on the most active exchanges. The market currently supplies 126.8 million shares, which translates into a market capitalization of roughly EUR 805.2 million. In the preceding 24 hours, about EUR 2.5 million worth of shares changed hands.

Despite this small uptick, Terveystalo’s share price remains markedly below its performance at the end of the previous month, reflecting a decline of 17.01 %. The 200‑day simple moving average stands at EUR 8.24, providing a benchmark for medium‑term momentum. Over the last 52 weeks, the share’s peak price was EUR 10.42 on 2 September 2026, while the trough was EUR 6.09 on 20 October 2026. These extremes illustrate the volatility inherent in the sector, even as the company maintains a solid presence in Finland’s healthcare landscape.

Comparative Performance in the 24‑Hour Window

Terveystalo’s movement can be contextualized by examining the recent performance of five related stocks:

Symbol24‑Hour MoveCurrent PriceMarket Cap (EUR mn)P/E Ratio
QTCOM.HE (Qt)+2.88 %34.28856.237.22
ALBAV.HE (ÅLandsbanken Abp)+1.85 %44.00678.113.71
POSTI.HE (Posti)0 %9.65592.318.86
HARVIA.HE (Harvia)+0.68 %44.70841.129.77
SCANFL.HE (Scanfil)–0.16 %12.88845.819.79

Qt, operating in the telecommunications sector, led the group with a nearly 3 % rise, suggesting a broader positive sentiment across Finnish equities. ÅLandsbanken Abp, a regional bank, also posted gains, whereas Scanfil edged slightly lower, indicating that sector‑specific dynamics continue to influence individual performances.

About Terveystalo

Terveystalo Oyj is a prominent Finnish healthcare provider headquartered in Helsinki. The company offers a comprehensive portfolio of services, encompassing general and occupational medicine, diagnostic imaging, laboratory testing, and clinical research. Its network of approximately 180 clinics serves a diverse client base that includes private individuals, corporate clients, community organizations, insurance firms, and public sector entities. By integrating insurance solutions and research capabilities, Terveystalo positions itself as a multifaceted partner in Finland’s health ecosystem.


This article provides a factual snapshot of Terveystalo’s recent trading activity, situating it within the broader context of related Finnish equities. It aims to present complex market information in a clear, accessible manner for readers interested in corporate developments.